NCT04988685Recruiting
SIROOP Registry - A Prospective Registry Study to Evaluate the Outcomes of Coronary Artery Disease Patients Treated With SIROlimus Or Paclitaxel Eluting Balloon Catheters
Source: ClinicalTrials.gov · Last updated 29 Oct 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The purpose of the SIROOP Registry is to retrospectively and prospectively collect baseline, clinical and procedural characteristics of patients who have undergone PCI and are treated with either currently available sirolimus or paclitaxel coated DCBs (see Table 1), irrespective of clinical presentation as well as to prospectively collect data about their clinical outcomes. Outcomes will be compared in different clinical subgroups. The impact of current DCBs in different clinical settings and coronary artery lesions on cardiovascular outcomes will be assessed.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 2000 (estimated)
- First submitted
- 25 Jul 2021
- Start date
- 1 Jun 2021
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Luzerner Kantonsspital
- Diseases
- Coronary artery disease
- NCT number
- NCT04988685
What you commit to
- Study type: Observational
- Planned participants: 2000
- From 1 Jun 2021 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Indication for surgical revascularization
Age
- Patient is \<18 years of age
Other
- Patient unwilling or unable to provide informed consent
- pregnancy and lactation
Who the study is looking for
- Subject \>18 years of age
- Patients with significant acute or chronic coronary de-novo lesions or ISR lesions requiring treatment using PCI
- Treatment with at least one DCB (device choice at the operator's discretion) In case of a patient with lesions treated at different procedural time, lesions will be separately collected and documented
- Subjects must be willing to sign a patient informed consent (PIC) or must have signed the General Consent (GK).
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Luzerner Heart Centre Coordinator of this site? Confirm its status | Lucerne | Switzerland | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.